[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@GeneInvesting Avatar @GeneInvesting Gene Investing w/Anthony 🧬

Gene Investing w/Anthony 🧬 posts on X about $ntla, $beam, $prme, $crsp the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence finance XXXXX% stocks XXXX% cryptocurrencies #5426 technology brands XXXX% social networks XXXX% celebrities XXXX% countries XXXX%

Social topic influence $ntla #2, $beam #2, $prme #1, $crsp #2, $alny #2, $bbio #2, money 0.52%, alltime #646, stocks 0.39%, want a #511

Top accounts mentioned or mentioned by @vega_n1 @jessiechimni @rnaianalyst @bk7959925597715 @crisprspace @elikorey @vegan1 @carefree201215 @janvdes @devineni6 @biomedicalrx @hassanaesthetic @jfais20 @freshjiva @biopharmiq @zhaoweiasu @stonkeddie @lovebostrom @bambossie81 @masterlongevity

Top assets mentioned Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) CRISPR Therapeutics AG (CRSP) Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) Hims & Hers Health, Inc. (HIMS) Sarepta Therapeutics, Inc. (SRPT) Bristol-Myers Squibb Co (BMY) Bluefin (BLUE) Bitcoin Incognito (XBI) BioMarin Pharmaceutical, Inc. (BMRN) uniQure N.V. (QURE) Vertex Protocol (VRTX) Regeneron Pharmaceuticals Inc (REGN) 4 (4) Protagonist Therapeutics, Inc (PTGX) Johnson & Johnson (JNJ)

Top Social Posts #

Top posts by engagements in the last XX hours

"@VEGA_n1 XXX has already shown data. New data probably just extends it farther. It wont double on that extension of data. I doubt there will be a second target announcement in next X years but liver should be announced next year Id expect. XXX timeline is very unknown at this point"
X Link @GeneInvesting 2025-10-11T16:02Z 14.4K followers, XX engagements

". @MartinShkreli joined me on Spaces X years ago. This is from October 3rd 2023 X years of successful advancement by the company and you can buy for roughly the same valuation $X billion. $NTLA He also did a YouTube video where he called Intellia his favorite biotech of all-time 💪"
X Link @GeneInvesting 2025-10-06T21:21Z 14.5K followers, 6914 engagements

"12 Reasons Why Intellia Therapeutics is My All-In 👇 X. Three Phase X trials $NTLA has the only three in vivo CRISPR Ph. X trials in the world 🌎 X. In vivo higher margins 💰 much faster + easier administration 💨 2-4 hour outpatient drip 💧 X. LNP not AAV unlike previous gene therapy NTLA delivers with LNP not AAV (which is notorious for safety problems) ☠ X. The next CRISPR FDA approval in XX months second: XX months after that third: XX months after that X. ATTR is a massive market $XX billion peak 👀 HAE is slept on $5b market in 2028 X. Patients are lining up NTLA has already dosed 750"
X Link @GeneInvesting 2025-10-14T17:20Z 14.5K followers, 5928 engagements

"@zhaoweiasu I think you meant *not a demand issue. Considering Vertex is backing and pushing Casgevy I highly doubt its a supply problem"
X Link @GeneInvesting 2025-10-12T00:21Z 14.5K followers, XXX engagements

"Thank you for making my day @liteupthedark1 🥹 $NTLA I should get paid more for this level of comedy I bring to people. Stock was $XX when we had this conversation"
X Link @GeneInvesting 2025-10-06T16:19Z 14.5K followers, 3643 engagements

"@bob_bob2131 XX months Revenue thinking only works if the drug is selling if not its a drag on stock price"
X Link @GeneInvesting 2025-10-12T14:47Z 14.5K followers, XX engagements

"@SevenParr $NTLA $BEAM"
X Link @GeneInvesting 2025-10-12T21:12Z 14.5K followers, XXX engagements

"@StonkEddie Most of these are December or next year and early. $NTLA is in X weeks. So my point remains valid. XXX everyone and their mother is doing. The T1 diabetes has little hope. But I am looking forward to 112/131"
X Link @GeneInvesting 2025-10-10T14:26Z 14.5K followers, XXX engagements

"@Dadbod4evah I have so many receipts I could write a novel"
X Link @GeneInvesting 2025-10-01T17:08Z 14.4K followers, XXX engagements

"@Marahayter Itll be interesting for sure. Id imagine someone would want a piece of ATTR market at least"
X Link @GeneInvesting 2025-10-14T17:46Z 14.5K followers, XXX engagements

"@Matt_vlietstra Currently $NTLA $BEAM and $PRME would be next"
X Link @GeneInvesting 2025-10-14T12:49Z 14.5K followers, XXX engagements

"This thing is relentless 😤 $NTLA"
X Link @GeneInvesting 2025-10-08T14:12Z 14.5K followers, 10.4K engagements

"@3primeAnalytica Dont like it here and it was my favorite for X years or so. Need Wave 2/3 SCD to move faster and to get significant AATD rights to Primes version. Then its interesting depending on price of course. Also want to know their Pfizer target"
X Link @GeneInvesting 2025-10-11T04:50Z 14.4K followers, XXX engagements

"Very interesting that $NTLA isnt listed. Intellias website had this as an event for Tuesday yet when I checked yesterday it disappeared 🤔 Why would they decide to cancel it $CRSP $PRME $BEAM and many others are still listed"
X Link @GeneInvesting 2025-10-12T20:55Z 14.5K followers, 13.1K engagements

"@allsugarzerota1 From this cool guy named Anthony aka Gene Investing. All data is accurate from the companies themselves. $ALNY had healthiest group of patients"
X Link @GeneInvesting 2025-10-13T13:54Z 14.5K followers, XXX engagements

"Fascinating. $ALNY $BBIO $NTLA $PFE Key here is the baseline Tafamidis subgroup This shows Tafamidis (stabilizer) does not help with gastrointestinal events yet Vutrisiran (silencer) does in a major way. 👀"
X Link @GeneInvesting 2025-09-29T19:16Z 14.5K followers, 2985 engagements

"2 for X Special 👋 Bet with @Biotech2k1 On 2/4/25 to today (8 months) $NTLA $XXXX ➡ $XXXXX (+154.4%) $BBIO $XXXXX ➡ $XXXXX (+67.7%) Bet with @techinvestoor ( X months ago) $NTLA 🟰 $XXXXX ➡ $XXXXX (+128.1%) $HIMS 🟰 $XXXXX ➡ $XXXXX (+29.0%)"
X Link @GeneInvesting 2025-10-08T20:07Z 14.5K followers, 6020 engagements

"Where did the bears go Im feeling lonely on here 🥹 $NTLA"
X Link @GeneInvesting 2025-10-01T18:12Z 14.5K followers, 5628 engagements

"Why so many CRISPR haters exist Most biotech investors have been burned by gene therapy at one point or another. $SGMO $BLUE $SRPT have all hurt the brokerage accounts of thousands of biotech investors. Those who have been around a long time have likely lost significant money in at least X of the X or one of the many other busts in gene therapy over the years. The few who havent been burned by gene therapy probably are invested in the chronic therapies of competitors. Why this time is different: in vivo LNP delivery no viral AAV delivery CRISPR gene therapy liver is easiest target 🎯 one and"
X Link @GeneInvesting 2025-10-02T12:15Z 14.5K followers, 12.6K engagements

"What are you most excited about when $NTLA data is released in X weeks"
X Link @GeneInvesting 2025-10-02T00:47Z 14.5K followers, 2717 engagements

"Up to 11800 shares of $NTLA"
X Link @GeneInvesting 2025-10-03T17:12Z 14.5K followers, 5586 engagements

"Was $XXXXX when I tweeted this morning Strong close. IMO dont be short going into data in X weeks. $NTLA"
X Link @GeneInvesting 2025-10-10T20:05Z 14.5K followers, 3995 engagements

"@planert41 X big data readouts in X weeks thats partly why"
X Link @GeneInvesting 2025-10-12T02:19Z 14.5K followers, XXX engagements

"Remind me which one the bears said should close their doors Looking forward to extending the bottom line in 25-28 days. $NTLA $ALNY $BBIO"
X Link @GeneInvesting 2025-10-13T13:49Z 14.5K followers, 7556 engagements

"Okay now I feel rich 💰 Thanks to everyone for interacting with my content and Im looking forward to X Spaces in X weeks for HAE and ATTR data 💪"
X Link @GeneInvesting 2025-10-11T00:29Z 14.5K followers, 2661 engagements

"@zhaoweiasu @3primeAnalytica Then that is very bad for beam"
X Link @GeneInvesting 2025-10-11T06:11Z 14.4K followers, XXX engagements

"Checking on my bet with @Biotech2k1 On 2/4/25 to today $NTLA $XXXX ➡ $XXXXX (+107.5%) $BBIO $XXXXX ➡ $XXXXX (+60.3%) Good start 💪"
X Link @GeneInvesting 2025-10-05T01:22Z 14.5K followers, 2413 engagements

"@Omegastar1111 They dont have a partnership with Pfizer but $BEAM does. $PRME has one big one with $BMY I expect another big partner for Prime at some point in next year"
X Link @GeneInvesting 2025-10-05T17:36Z 14.5K followers, XXX engagements

"@3primeAnalytica I think you expect Beam to magically treat XX% of AATD or something in first X years. I do think itll be successful I just dont like how many better drugs are coming from behind. And its sad because they couldve used PE"
X Link @GeneInvesting 2025-10-11T05:16Z 14.4K followers, XXX engagements

"Heres another fun example how sneaky $ALNY likes to be with their data See if you can spot the reason (on 2nd picture) their NT-proBNP looks way better than the reality of XXXX at XX months Comment below once you find it (I already did). $NTLA"
X Link @GeneInvesting 2025-09-28T16:17Z 14.5K followers, 2508 engagements

"Great story about the genetic form of ATTR available on @intelliatx website. Nancy and her father (Hyung) were diagnosed in 2019. $NTLA Out of Hyungs X siblings only he and one other are still alive. Siblings had cardiac related deaths likely due to undiagnosed ATTR. Hyung was fortunate to find a heart transplant donor match at XX (the story says a year ago but Ive seen this story for X years on the website so maybe in 2022). Heart transplants are typically limited to patients under XX. Tafamadis is the leading ATTR-CM drug in the world with $6b in sales and the data on that drug leaves"
X Link @GeneInvesting 2025-10-05T16:03Z 14.5K followers, 4456 engagements

"$19 holla The beast is back $NTLA"
X Link @GeneInvesting 2025-10-01T13:53Z 14.5K followers, 6195 engagements

"Is this true Seems hard to believe young chimps have zero cancer 🧐"
X Link @GeneInvesting 2025-10-12T16:31Z 14.5K followers, 3429 engagements

"Trump is giving everyone on last chance on $NTLA $PRME I wouldnt touch unless under $5"
X Link @GeneInvesting 2025-10-10T15:38Z 14.5K followers, 8628 engagements

"IMO it is now clear why the $CRSP board member invested $50m+ a few months ago 1) he saw preclinical AATD data 2) hes seen 112/131 cancer data 3) he knew lower interest rates would energize the sector 4) $XBI was more than due Most interesting to me will be how long he keeps that huge position considering hes already up huge"
X Link @GeneInvesting 2025-10-10T14:31Z 14.5K followers, 3431 engagements

"One of the premier KOLs in the ATTR-CM space @MasriAhmadMD He and his hospital are part of Intellias Magnitude Ph. X study. $NTLA Interesting comments on payers and how combo therapy is actually possible today (yet doctors typically avoid this due to unproven benefit). This could completely change once Magnitude reads out. 12/18/24/30 months Mono Vutri: 1.20/1.24/1.29/1.30 Overall ALNY: 1.08/1.07/1.20/1.19 (60% mono/40% combo) Vutri+Taf: 0.90/0.82/1.06/1.03 (Combo calculated by me) Seems odd to me the XXXX to XXXX jump (I hand calculated this long ago so I might need to recheck it)."
X Link @GeneInvesting 2025-10-13T22:47Z 14.5K followers, 2356 engagements

"Thought I responded to this back then but guess not. $NTLA X. As you mentioned price wont be $3m+ X. 2-4 hour drip as you mentioned X. No AAV delivery worries X. No gene therapy durability concerns X. $CRSP $VRTX and others have now spent years working with insurance"
X Link @GeneInvesting 2025-10-04T16:01Z 14.5K followers, 3497 engagements

"@SharpeShark $NTLA"
X Link @GeneInvesting 2025-10-04T23:19Z 14.5K followers, 1172 engagements

"And lets remember Intellias Class I/II would literally be off this graph Comparing $ALNY to $NTLA at 12m is like comparing prime Lebron James to Bronny. Heres the best part: XXXX% of Alnylam patients were Class I/II and they still had worsening of XX% on average at XX months. Intellias Class I/II 🟰 XXXX (3% improvement) And Intellia had one Class X who was variant and baseline 19600+ (the other companies had 8500 max). They died at Day XXX so its likely the XXXX wouldve been even better without them"
X Link @GeneInvesting 2025-10-14T15:03Z 14.5K followers, 4493 engagements

"@TheRealDanSfera Now i understand why everyone was freaking yesterday. Too much fart coin 😂"
X Link @GeneInvesting 2025-10-11T15:39Z 14.4K followers, XX engagements

"God please give me the strength to not laugh at those who said a company with THREE Ph. X best in class/cures was worthless. 🙏 $NTLA"
X Link @GeneInvesting 2025-10-09T16:31Z 14.5K followers, 2797 engagements

"The power of Jerome From -X% to +3.5% $NTLA"
X Link @GeneInvesting 2025-10-14T18:15Z 14.5K followers, 2607 engagements

"Just got muted and called a clown because I showed him our bet standings just like he did when he was up on X weeks ago 🤦🏻♂ $NTLA $HIMS"
X Link @GeneInvesting 2025-10-08T20:38Z 14.5K followers, 3378 engagements

"@TheRealDanSfera My $NTLA shorts are officially burnt to a crisp. They arent alive anymore"
X Link @GeneInvesting 2025-10-08T17:41Z 14.5K followers, 1405 engagements

"I wouldve paid a lot of money to watch Martin tell Adam how great $NTLA is 🤣 Adam: Whats your favorite biotech of all-time Martin: NTLA Adam: starts barfing uncontrollably 🤮"
X Link @GeneInvesting 2025-10-07T05:43Z 14.5K followers, 12.1K engagements

"@3primeAnalytica Not happening if $NTLA is that low too lol"
X Link @GeneInvesting 2025-10-11T05:56Z 14.4K followers, XXX engagements

"Fundamentals in X snapshot $NTLA vs $BBIO 🥹 @Biotech2k1"
X Link @GeneInvesting 2025-10-09T17:25Z 14.5K followers, 3020 engagements

"I was lucky and had the tab still open If you go to this page now it has disappeared. 🤔 $NTLA"
X Link @GeneInvesting 2025-10-13T18:55Z 14.5K followers, 6913 engagements

"Yeah pretty hilarious when HAE companies are forced to buy the competition. $NTLA Ive been telling $BCRX holders to get out of that name ASAP -XXXX% today $ATXS +39%"
X Link @GeneInvesting 2025-10-14T17:58Z 14.5K followers, 2271 engagements

"@VEGA_n1 Huge drag for now will be Casgevy sales and arbitration if it doesnt go well. If those X things look better I agree itll do well. I expect a double in X years"
X Link @GeneInvesting 2025-10-11T15:50Z 14.4K followers, XXX engagements

"@ReallyAugmented Because if it doesnt sell the Beam XXX which is their first approval wont get appreciated by Wall Street"
X Link @GeneInvesting 2025-10-12T15:56Z 14.5K followers, XX engagements

"@Alex___VA @VEGA_n1 Considering if $NTLA gets HAE approval in Q2 XX before $BEAM gets XXX and obviously assuming safety from both companies continues. Hard to see $NTLA being worth less but I could see similar"
X Link @GeneInvesting 2025-10-11T19:35Z 14.4K followers, XXX engagements

"Flashback When Bernstein came up with a $XX target by being most bullish on AATD and I said AATD should be counted as a zero for the company. $NTLA discontinued their AATD program (3001) TWO days later They also said Ph. X HAE trial will be different than Ph. X (untrue)"
X Link @GeneInvesting 2025-10-13T03:17Z 14.5K followers, 3860 engagements

"Ill take this opportunity to remind everyone of Martins favorite biotech of all-time $NTLA"
X Link @GeneInvesting 2025-10-06T20:57Z 14.5K followers, 11.4K engagements

"$26 😳 $NTLA $XX ✅ $XX ✅ $XX ✅ $XX ✅ $XX ✅ All today 😤"
X Link @GeneInvesting 2025-10-08T16:16Z 14.5K followers, 4401 engagements

"People on X: Hey Anthony what is the best gene editing stock $BEAM $NTLA $CRSP $PRME"
X Link @GeneInvesting 2025-10-10T01:00Z 14.5K followers, 3204 engagements

"@StockSavvyShay All in $NTLA baby 💪"
X Link @GeneInvesting 2025-10-08T17:21Z 14.4K followers, XXX engagements

"Good post discussing $BEAM and how theyve brought in big money 💰 Im rooting for them but cant get myself to back AATD which I was positive on but now see many threats (. $PRME $CRSP Tessera and multiple RNA editing competitors) and Wave X SCD. My popcorn is ready for Prime vs Beam arbitration announcement in 1H next year. 🍿"
X Link @GeneInvesting 2025-10-11T04:35Z 14.5K followers, 6161 engagements

"BEAST MODE ACTIVATED $NTLA If you have a love one who is a bear go check on them. They need our support 🥹 $XX ✅ $XX ✅ $XX ✅ $XX ✅ This is a true @Maximus_Holla today"
X Link @GeneInvesting 2025-10-08T15:22Z 14.5K followers, 5995 engagements

"@3primeAnalytica Its going to be a very interesting Q4"
X Link @GeneInvesting 2025-10-13T00:56Z 14.5K followers, XXX engagements

"@VEGA_n1 That AATD data is key because stock wont move much on SCD until Casgevy shows there is money there"
X Link @GeneInvesting 2025-10-11T16:06Z 14.5K followers, XX engagements

"@VEGA_n1 That would be HORRIBLE for Beam. Stock wise it would be disaster if Prime is seen as wearing the pants in that relationship"
X Link @GeneInvesting 2025-10-11T16:04Z 14.4K followers, XX engagements

"I cant even keep up with this insane monster. $NTLA $XX AND $XX holla today 👀"
X Link @GeneInvesting 2025-10-08T14:33Z 14.5K followers, 3093 engagements

"A timeline of @adamfeuerstein s commentary on $NTLA is hilarious. I found the exact moment that turned him against the company 2/28/22 NTLA refuses to abide by its side of the NTLA-2001 embargo agreement. The company is restricting access to certain data that should be shared in advance w/ reporters who have agreed to common embargo terms. This is unprofessional and disrespectful. (His feelings got hurt) 2/28/22 NTLA shows improved sustained effect from in vivo CRISPR treatment and But. as these data are announced the seemingly never-ended CRISPR patent fight lands with another win for the"
X Link @GeneInvesting 2025-10-04T14:16Z 14.5K followers, 1963 engagements

"@VEGA_n1 @Biotech2k1 According to him $NTLA must have better fundamentals now 🤷🏻♂ I dont make the rules he does"
X Link @GeneInvesting 2025-10-09T18:37Z 14.5K followers, XXX engagements

"@LoveBostrom @VEGA_n1 Only X liver target but yes Im looking forward to seeing it"
X Link @GeneInvesting 2025-10-11T17:15Z 14.4K followers, XX engagements

"@Architect9000 This should be my advertisement for why someone should invest in $NTLA 😂"
X Link @GeneInvesting 2025-10-09T22:04Z 14.4K followers, XXX engagements

"WOW 😮 Just realized $ALNY reversal counts any patient that has nMIS+7 reduce by any amount (even -0.1) $NTLA is even stronger than I thought. Only XX% of ALNY Vutri patients had a lower value at XX months. This means XX% had a worse value or small chance of no change at all. Looking at XX NTLA patients 15/18 obtain this (83.3%) at XX months. And the X who dont X progressed on Vutri also Second only had a X baseline Third only had a X baseline and stayed a 2"
X Link @GeneInvesting 2025-09-27T17:17Z 14.5K followers, 6713 engagements

"Love seeing families stand up to people like Adam F. Patients and their families advocating can make a big difference $SRPT"
X Link @GeneInvesting 2025-10-13T00:53Z 14.5K followers, 5399 engagements

"PREVIEW Me in X month So far $NTLA has collected the Polyneuropathy Stone ✅ Next is likely the HAE Stone Finally the Cardiomyopathy Stone to complete the gauntlet 💪 Bears will disappear"
X Link @GeneInvesting 2025-10-06T13:27Z 14.5K followers, 2532 engagements

"How are we supposed to go about our daily lives when $NTLA is so close to dropping TWO big data readouts"
X Link @GeneInvesting 2025-10-15T03:33Z 14.5K followers, 1185 engagements

"@Gabrielmendesnu Dont need any others if these X pan out. Hem B is milestones and small royalties and thats also in clinic through $REGN now"
X Link @GeneInvesting 2025-10-14T15:30Z 14.5K followers, XXX engagements

"@Kross_Roads Youre a big boy now 🥹"
X Link @GeneInvesting 2025-10-11T05:56Z 14.4K followers, XXX engagements

"Which CRISPR company will have MORE REVENUE each year 2026: $CRSP 2027: CRSP 2028: NTLA 2029: NTLA 2030: NTLA 2031: NTLA 2032: NTLA 2033: NTLA or BEAM 2034 $NTLA or $BEAM or $PRME 2035 NTLA or BEAM or PRME"
X Link @GeneInvesting 2025-10-03T13:11Z 14.5K followers, 5841 engagements

"Love this guy because he gives me free comedy every week. He sold $NTLA at $XXXXX only X months ago. Now at $XXXXX he missed out on XX% already. There is zero oral HAE drug on the market that is close to Intellia. There is zero oral ATTR drug on the market that is close to Intellia (he thinks BBIO is just as good and its not close). This will become extra clear in X weeks"
X Link @GeneInvesting 2025-10-02T21:18Z 14.5K followers, 7882 engagements

"The serum doesn't have a commercial name yetit's a research formulation from Schweitzer Biotech in Taiwan. Key ingredients: Centella asiatica extracts IGF-1 FGF-7 caffeine and vitamin B5. A study showed XX% hair density increase in XX days. More trials needed. -Grok"
X Link @GeneInvesting 2025-10-13T01:57Z 14.5K followers, 3547 engagements

"@devineni6 @longoption @JessieChimni @BiomedicalRX @yaireinhorn @iHooghvorst Thanks. Gene editing is my favorite and $NTLA $BEAM and $PRME. $CRSP is the biggest safest due to cash but not exactly super cheap anymore"
X Link @GeneInvesting 2025-10-06T03:50Z 14.5K followers, XXX engagements

"@Alex___VA $BEAM just got walloped by $CRSP and $PRME on AATD so the arbitration becomes extra important now"
X Link @GeneInvesting 2025-10-10T15:50Z 14.5K followers, XXX engagements

"Brb have to grab tissue. 🥹 $NTLA"
X Link @GeneInvesting 2025-10-07T16:12Z 14.5K followers, 3033 engagements

"Im honestly worried about this man most of them rallied XXX% before I sold them. 🤔 🥹 XXX% is a 6x and I know of exactly ZERO of his stocks that he recently sold that went 6x from lows. He sold $NTLA at $XXXXX 2x from lows He sold $CRSP at $XXXXX barely above recent lows. $IPSC sale was likely XX% above lows $MGX at $XXXX was 2x from lows $PRME sale at $XXXX was 5x lows. So 4/5 of these didnt come close to his 6x statement. I wont even get into others like NVTA DNA etc"
X Link @GeneInvesting 2025-10-10T15:20Z 14.5K followers, 2671 engagements

"@topsecretstocks I saw $PRME Right now my favorites are: 1) $NTLA 2) $BEAM 3) PRME"
X Link @GeneInvesting 2025-10-12T01:04Z 14.5K followers, XXX engagements

"Doctor to patient ATTR-PN conversation $NTLA $ALNY Doctor: Do you want a XX% chance to lower your nMIS+7 or a XXXX% chance Patient: XXXX% sounds better lets do that Doctor: Do you want to lower by XXX points on average or only XXXX points Patient: Is this a trick question Doctor: Do you want a XX% chance to worsen by XX points on average or a XXX% chance to worsen by XX Patient: Am I being punkd Doctor: Last question: do you want only X 2-4 hour treatment Or do you want X treatments per year Patient: Please tell me all of these good options are the same drug. Doctor: Youre in luck 😉"
X Link @GeneInvesting 2025-09-28T01:01Z 14.5K followers, 16K engagements

"Soon Ill get a lot of podcast requests This is how it tends to happen 😅 $NTLA First comes max bear hate calling me mentally ill for investing in cures Second the bears go into denial Third they disappear in shame Fourth I get asked to be on podcasts 😂"
X Link @GeneInvesting 2025-10-08T18:54Z 14.5K followers, 3172 engagements

"I also need to dispel this notion that $NTLA isnt adding anything beyond what $ALNY has already achieved. Its simply not close to being true. Nt-proBNP for Vutri at 12m was XX% worse than baseline despite only XXX% Class III patients and XX% variant. It was only X% worse for Nex Z despite XX% Class III XX% variant and multiple patients with baselines well above the 8500 limit of BBIO and ALNY. Also for Class I/II which was XXXX% of ALNY Nex Z actually improved by 3%. Nex Z is highly differentiated versus Vutrisiran in ATTR PN and CM. For PN Nex Z had -XXX average improvement on nMIS+7 and"
X Link @GeneInvesting 2025-10-04T22:55Z 14.5K followers, 3099 engagements

"Ill leave this here $NTLA Stock has tripled (+200%)"
X Link @GeneInvesting 2025-10-01T16:59Z 14.5K followers, 3954 engagements

"So on Thursday I decided to do what I think was a pretty cool trade I bought $NTLA shares at $XXXXX. Sold CCs for April at $XX strike for $X (each contract is XXX shares so it gave me $XXX in premium per contract). Basically means I paid $XXXXX and retained upside to $XX. NOT BAD I think it was a spectacular way to get into the stock for those who felt they missed it and wanted a price closer to $XX. Considering my most conservative fair value is $XX (which might go to $XX on good data in X weeks) I still love the stock $XX. P.S. I have way more shares now 😤"
X Link @GeneInvesting 2025-10-11T04:13Z 14.5K followers, 3928 engagements

"Idea 💡 Whats stopping an HAE patient from telling their doctor they are having attacks (even if they arent) and want the cure from $NTLA Assume we are in 2027/2028 and insurance plays hard ball on some patients because theyve been well controlled. They could even stop medication to take pictures of an attack if insurance is requiring proof. Insurance isnt going to drug test these people 😂"
X Link @GeneInvesting 2025-10-07T15:28Z 14.5K followers, 2442 engagements

"I was close to doing X years but this isnt ahead this is for a shot at best revenue. Beam XXX will be slow and it comes down to a lot of unknowns about AATD and WD and you notice I put all X because its too far away to guess. Prime needs everything to go perfect and lots of unknowns to be in that ballpark but I was being nice to my Prime peeps"
X Link @GeneInvesting 2025-10-03T13:40Z 14.5K followers, XXX engagements

"@3primeAnalytica If it was $2b Id consider it. Problem is $NTLA always looks better in a X year timeframe to me"
X Link @GeneInvesting 2025-10-11T05:52Z 14.5K followers, XXX engagements

"And this is why stop losses are a fools game in smid biotech. You know how many people probably sold Friday or after hours when $NTLA was down X% on no company specific news Closed AH essentially flat and market looks very green for Monday. But obviously Trump could tweet again and it all reverses 😂"
X Link @GeneInvesting 2025-10-12T23:46Z 14.5K followers, 4692 engagements

"$20 DOLLA HOLLA 😤 But remember $NTLA shouldve closed its doors at $X four months ago"
X Link @GeneInvesting 2025-10-02T17:01Z 14.5K followers, 12.5K engagements

"Big morning in gene editing☀ 1) $CRSP unveiled what appears to be strong preclinical AATD data w/ their new gene correction tech obviously behind $BEAM and $PRME but puts extra pressure on BEAM to get significant rights to PRMEs program through arbitration imo 2) Beams spinoff for RNA editing Orbital was purchased for $1.5b by Bristol Myers Squibb 3) NTLA essentially confirmed HAE data will be Nov 6-10 (due to not stating data at the upcoming HAE event)"
X Link @GeneInvesting 2025-10-10T13:55Z 14.5K followers, 3996 engagements

"@StonkEddie Dude $NTLA is the one who has the most important data coming up the soonest and has performed the best recently. Of course that is going to get the vast majority of attention. You notice as soon as the others finally had news today I posted it"
X Link @GeneInvesting 2025-10-10T14:21Z 14.5K followers, XXX engagements

"Time for another Where We Stand in CRISPR Land $NTLA $BEAM $PRME $CRSP Rankings X Intellia (2-3x XX month potential) HAE and CM data in X weeks are HUGE FDA approval is only XXX years away for HAE (the next CRISPR approval) large CM trial could fully enroll in next XX months ex-US HAE deal for cash 💰 2-3x by end of 2027. X Beam (2x possibly 3x if Casgevy wakes up etc) Orbital sale is huge. Someone predicted $270-$300m to Beam I predict some of this money gets used in Prime arbitration to expand their partnership more Wave X (chemo) SCD hinges on whether or not Casgevy starts selling better"
X Link @GeneInvesting 2025-10-11T23:00Z 14.5K followers, 23.1K engagements

"@VEGA_n1 $NTLA should burn less but it is true that milestones for $BEAM will help tighten the gap. Both are strong choices here"
X Link @GeneInvesting 2025-10-11T19:56Z 14.4K followers, XX engagements

"Im predicting @davidrliu will be awarded a Nobel Prize on Monday or Wednesday $PRME $BEAM Keep an eye out 👀 11:30 CEST is 2:30am PT/5:30am ET"
X Link @GeneInvesting 2025-10-06T02:30Z 14.5K followers, 16.2K engagements

"So the $ALNY gen X drug finally started pivotal Ph. X. Up to X locations. Enrolling 1250 patients. Will be very key the gap between $NTLA approval and this approval. Ill assume 12-18+ month headstart on commercial for Intellia. Will be interesting if both go for interim analysis before XX months. Alnylam is again only taking 8500 on NT-proBNP and they estimated XX months with max of X years. Intellias pivotal takes 10000. Time frame is set at minimum of XX months up to XX months"
X Link @GeneInvesting 2025-09-28T21:40Z 14.5K followers, 2491 engagements

"@masterlongevity Then we really hope they bust out more info this time"
X Link @GeneInvesting 2025-10-14T16:57Z 14.5K followers, XX engagements

"The truth is $NTLA 2001 (Nex Z) is technically a cure if given early enough Yet it is rarely caught in wildtype version (90%+ of cases) until build up is significant. Positive is that diagnosis is getting earlier and all drugs will have better outcomes thanks to that. Would very likely be a cure for variant CM or PN patients who had a family member with it got tested and could get it before build up gets too significant. Great example of how biotech is not often black and white. There was also zero Grade X liver injury only a transient elevation. Elevation does not equal injury. No Hys Law"
X Link @GeneInvesting 2025-10-04T16:52Z 14.5K followers, 2443 engagements

"@3primeAnalytica @aditharun_ Lets not forget tons of patient stories from $NTLA for their HAE cure 💪"
X Link @GeneInvesting 2025-10-12T22:17Z 14.5K followers, XXX engagements

"@VEGA_n1 Obviously stocks move or dont move sometimes but not smart to expect moves on XXX or XXX thats for sure imo"
X Link @GeneInvesting 2025-10-11T16:11Z 14.5K followers, XX engagements

"Not seeing many posts about this potential M&A. Johnson and Johnson $JNJ appears to be buying $PTGX Reported by the Wall Street Journal today. Stock is currently $XXX billion after todays move so not a small acquisition. PTGX and JNJ are already codeveloping a treatment for ulcerative colitis"
X Link @GeneInvesting 2025-10-10T16:56Z 14.5K followers, 1776 engagements